A Six-Hydrogen-Bonded Molecular Duplex
J. Am. Chem. Soc., Vol. 122, No. 11, 2000 2643
2-(Octyloxy)-5-nitrobenzoic Acid (III). The ester II (3.09 g, 10
mmol) was dissolved in hot MeOH (40 mL), to which 1 N NaOH (20
mL, 20 mmol) was added. The mixture was heated under relux for
30-40 min, and more water (100 mL) was added. The aqueous layer
was neutralized by addition of concentrated HCl to pH 3.0. The
precipitated crude product was collected, and recrystallization from
acetyl chloride (0.79 g, 10 mmol) over 5 min at 0 °C, after which the
ice-water bath was removed. After 6 h, the solvent was evaporated,
the residue was dissolved in ethyl acetate, and the solution was washed
with diluted HCl and NaOH solutions alternatively. Drying and
evaporation of the solvent gave the crude product, which was
recrystallized from MeOH, giving the pure product as a white solid
1
1
MeOH gave a white solid (2.66 g, 90%). H NMR (CDCl3): δ 10.62
(3.56 g, 90%). H NMR (CDCl3): δ 8.70 (s, 1H), 8.13 (q, J ) 2.4,
8.8, 1H), 7.83 (d, J ) 2.4, 1H), 7.38 (s, 1H), 6.96 (d, J ) 8.8, 1H),
4.25 (q, J ) 8.8, 14.0, 4H), 4.13 (t, J ) 6.6, 2H), 2.17 (s, 3H), 1.93
(br, 1H), 9.04 (d, J ) 2.8, 1H), 8.43 (q, J ) 2.8, 9.2, 1H), 4.34 (t, J )
6.6, 2H), 1.97 (m, 2H), 1.51 (m, 2H), 1.41-1.29 (m, 8H), 0.89 (t, J )
6.8, 3H). 13C NMR (CDCl3): δ 129.87, 129.63, 129.55, 118.79, 113.09,
71.41, 71.33, 31.67, 29.09, 20.04, 28.75, 25.75, 22.58, 14.01. Anal.
Calcd for C15H21NO5: C, 61.00; H, 7.17; N, 4.74. Found: C, 60.89;
H, 7.21; N, 4.79.
(m, 2H), 1.48 (m, 2H), 1.37-1.29 (m, 12H), 0.88 (t, J ) 6.4, 3H). 13
C
NMR (CDCl3): δ 169.76, 168.49, 164.96, 153.89, 131.80, 125.59,
123.24, 120.64, 113.06, 69.74, 61.41, 42.16, 31.78, 29.27, 29.20, 29.07,
26.14, 24.35, 22.63, 14.19, 14.06. Anal. Calcd for C21H32N2O5: C,
64.26; H, 8.22; N, 7.14. Found: C, 64.51; H, 8.45; N, 7.16.
N-((Ethoxycarbonyl)methyl)-2-(octyloxy)-5-nitrobenzamide (3a).
The acid III (2.95 g, 10 mmol) was dissolved in 10 mL of thionyl
chloride, and the mixture was heated under reflux with a calcium
chloride drying tube for 2 h. The solvent was removed in vacuo, and
anhydrous ether (2 × 30 mL) was added and then removed. The crude
acid chloride was directly used for the next step without further
purification.
N-(Carboxymethyl)-5-acetamido-2-(octyloxy)benzamide (3d). Hy-
drolysis of 3c based on the procedures described for 1c gave the crude
product, which was crystallized from MeOH, to give the pure product
1
as a white solid (97%). H NMR (DMSO): δ 12.80 (br, 1H), 9.95 (s,
1H), 8.52 (t, J ) 5.0, 1H), 8.0 (s, 1H), 7.78 (d, J ) 8.8, 1H), 7.10 (d,
J ) 8.4, 1H), 4.08 (t, J ) 6.2, 2H), 4.01 (d, J ) 3.6, 2H), 2.0 (s, 3),
1.80 (m, 2H), 1.40-1.24 (m, 10H), 0.843 (t, J ) 6.2, 3H). 13C NMR
(DMSO): δ 171.07, 167.99, 164.23, 152.49, 132.64, 123.59, 121.71,
121.19, 113.57, 69.16, 41.55, 31.20, 28.70, 28.62, 28.43, 25.53, 23.78,
22.07, 13.96. Anal. Calcd for C19H28NO5: C, 62.62; H, 7.74; N, 7.69.
Found: C, 62.62; H, 7.97; N, 7.68.
Octyl 3,5-Dinitrobenzoate (3e). To a solution of 3,5-dinitrobenzoyl
chloride (18.5 g, 80 mmol) and triethylamine (8.1 g, 80 mmol) in 250
mL of methylene chloride was added dropwise 1-octanol in 40 mL of
methylene chloride over 5 min at 0 °C. The ice-water bath was
removed. After 6 h, the solvent was evaporated and the residue was
dissolved in ethyl acetate and washed with diluted HCl and NaOH
solutions alternatively. The ethyl acetate solution was dried over Na2-
SO4. Evaporation of the solvent and recrystallization of the crude
product from MeOH gave the product as a white solid (25.9 g, 84%).1H
NMR (CDCl3): δ 9.22 (t, J ) 2.0, 1H), 9.16 (d, J ) 2.0, 2H), 4.48 (t,
J ) 2.0, 2H), 1.83 (m, 2H), 1.47-1.29 (m, 10H), 0.88 (t, J ) 6.6,
3H). 13C NMR (CDCl3): δ 162.23, 148.43, 133.93, 129.04, 121.92,
66.83, 31.43, 28.84, 28.25, 25.58, 22.29, 13.71. Anal. Calcd for
C15H20N2O6: C, 55.55; H, 6.22; N, 8.64. Found: C, 55.45; H, 6.34; N,
8.70.
Octyl 3,5-Diaminobenzoate (3f). Hydrogenation of 3e based on
procedures similar to those described for 1e gave crude 3f (90%), which
was used directly for the next step without further purification. 1H NMR
(CDCl3): δ 6.78 (d, J ) 1.6, 2H), 6.18 (s, 1H), 4.25 (t, J ) 6.6, 2H),
3.67 (s, 4H), 1.73 (m, 2H), 1.42-1.28 (m, 10H), 0.88 (t, J ) 6.0, 3H).
13C NMR (CDCl3): δ 166.91, 147.47, 132.56, 106.94, 105.55, 64.97,
31.80, 29.25, 29.19, 28.76, 26.05, 22.63, 14.05. Anal. Calcd for
C15H24N2O2: C, 68.15; H, 9.15; N, 10.60. Found: C, 68.14; H, 9.14;
N, 10.67.
To a solution of glycine ethyl ester hydrochloride (10 mmol) and
2.02 g (20 mmol) of triethylamine in CH2Cl2 was added a solution of
the above prepared acid chloride in 40 mL of methylene chloride over
a period of 5 min at 0 °C. The ice-water bath was removed, and the
reaction mixture was allowed to warm to room temperature. After 6 h,
the solvent was evaporated, the residue was dissolved in ethyl acetate,
and the solution was washed alternatively with diluted HCl and NaOH
solutions. Drying over Na2SO4 and evaporation of solvent gave the
crude product, which was recrystallized from MeOH, to give the product
as a white solid (3.61 g, 95%). 1H NMR (CDCl3): δ 9.10 (d, J ) 2.8,
1H), 8.44 (s, 1H), 8.32 (q, J ) 3.4, 9.2, 1H), 7.08 (d, J ) 9.2, 1H),
2.26 (m, 6H), 2.01 (m, 2H), 1.508 (m, 2H), 1.41-1.29 (m, 13H), 0.88
(t, J ) 6.8, 3H). 13C NMR (CDCl3): δ 169.70, 162.91, 161.55, 141.72,
128.56, 128.21, 121.70, 112.54, 70.70, 61.57, 42.26, 31.75, 29.19, 29.14,
28.81, 26.07, 22.61, 14.18, 14.05. Anal. Calcd for C19H28N2O6: C,
59.98; H, 7.42; N, 7.37. Found: C, 59.93; H, 7.34; N, 7.47.
N-Hexyl-2-(octyloxy)-5-nitrobenzamide (4a). This compound was
synthesized by the same procedure used for preparing 3a. Yield: 3.10
g, 82%. 1H NMR (CDCl3): δ 9.10 (d, J ) 2.8, 1H), 9.29 (q, J ) 2.8,
8.8, 1H), 7.78 (s, 1H), 7.05 (d, J ) 9.2, 1H), 4.23 (t, J ) 6.6, 2H),
3.47 (m, 2H), 1.93 (m, 2H), 1.61 (m, 2H), 1.51 (m, 2H), 1.41-1.30
(m, 14H), 0.90 (m, 6H). 13C NMR (CDCl3): δ 162.90, 161.13, 141.91,
128.52, 127.70, 122.84, 112.41, 70.32, 40.11, 31.75, 31.54, 29.49, 29.27,
29.19, 29.10, 26.83, 26.17, 22.60, 22.59, 14.01, 13.99. Anal. Calcd for
C21H34N2O4: C, 66.65; H, 9.06; N, 7.40. Found: C, 66.53; H, 9.22; N,
7.48.
N-((Ethoxycarbonyl)methyl)-5-amino-2-(octyloxy)benzamide (3b).
Compound 3a was reduced by catalytic hydrogenation in methanol at
room temperature, using Pd-C (10%) as the catalyst. Removal of
catalyst and solvent gave the crude product, which was used for the
next step without isolation and further purification. Typical yield: 90-
Octyl 3,5-Bis[(((((5-acetamido-2-(octyloxy)phenyl)carbonyl)ami-
no)methyl)carbonyl)amino]benzoate (3). To a solution of acid 3d
(3.64 g, 10 mmol), 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide
hydrochloride (1.92 g, 10 mmol), and 1-hydoxybenzotriazole (1.35 g,
10 mmol) in 30 mL of dimethylformamide (DMF) was added the
diamine 3f (1.32 g, 5 mmol) in 10 mL of DMF. The reaction was
allowed to proceed overnight. Distilled water (50 mL) was then added
to the reaction mixture. The precipitated solid was filtered off and stirred
with anhydrous MeOH under reflux for 2 h. The solution was cooled
to room temperature and filtered, giving the crude product. Recrystal-
lization from DMF/CHCl3 gave the pure product as a white solid (2.6
1
95%. H NMR (CDCl3): δ 8.74 (s, 1H), 7.56 (d, J ) 2.8, 1H), 6.79
(m, 2H), 4.24 (q, J ) 6.6, 13.2, 4H), 4.05 (t, J ) 6.6, 2H), 3.54 (s,
2H), 1.90 (m, 2H), 1.46 (m, 2H), 1.35-1.28 (m, 13H), 0.88 (t, J )
6.8, 3H). 13C NMR (CDCl3): δ 169.97, 165.36, 150.66, 140.04, 121.40,
119.70, 118.48, 114.02, 69.94, 61.26, 42.07, 31.78, 29.29, 29.21, 26.17,
22.63, 14.19, 14.06. Anal. Calcd for C19H30N2O4: C, 65.11; H, 8.63;
N, 8.00. Found: C, 64.82; H, 8.71; N, 7.97.
N-Hexyl-5-amino-2-(octyloxy)benzamide (4b). This compound was
prepared by the same procedure for used preparing 3b. 1H NMR
(CDCl3): δ 8.154 (s, 1H), 7.57 (d, J ) 3.2, 1H), 6.76 (m, 2H), 4.01 (t,
J ) 6.4, 2H), 3.53 (s, 2H), 3.44 (q, J ) 6.8, 12.8, 2H), 1.82 (m, 2H),
1.59 (m, 2H), 1.46 (m, 2H), 1.43-1.29 (m, 14H), 0.89 (t, J ) 6.4,
6H). 13C NMR (CDCl3): δ 165.21, 150.17, 140.34, 122.42, 118.97,
118.51, 113.95, 69.72, 39.77, 31.80, 31.60, 29.56, 29.51, 29.38, 29.26,
26.89, 26.30, 22.63, 22.61, 14.06. Anal. Calcd for C21H36N2O2: C,
72.38; H, 10.41; N, 8.04. Found: C, 72.38; H, 10.40; N, 8.21.
1
g, 56%). H NMR (DMSO): δ 10.36 (s, 2H), 9.92 (s, 2H), 8.66 (t,
J ) 4.8, 2H), 8.10 (s, 1H), 8.05 (d, J ) 2.8, 2H), 8.02 (d, J ) 1.2,
2H), 7.79 (q, J ) 2.8 Hz, 9.2, 2H), 7.12 (d, J ) 9.2, 2H), 4.24 (t, J )
6.6, 2H), 4.19 (d, J ) 2.4, 4H), 4.11 (t, J ) 6.4, 4H), 2.00 (s, 6H),
1.83 (m, 4H), 1.69 (m, 2H), 1.41-1.14 (m, 26H), 0.82 (t, J ) 6.6,
3H), 0.741 (t, J ) 6.6, 6H). 13C NMR (DMSO): δ 167.76, 167.35,
165.29, 164.14, 152.46, 139.25, 132.57, 130.66, 123.50, 121.72, 121.27,
114.75, 113.93, 113.50, 69.24, 64.57, 43.44, 31.01, 28.57, 28.48, 28.44,
28.38, 28.05, 25.58, 25.25, 23.59, 21.84, 21.82, 13.66, 13.62. Anal.
Calcd for C53H76N6O10: C, 66.50; H, 8.00; N, 8.78. Found: C, 66.12;
H, 8.12; N, 8.79.
N-((Ethoxycarbonyl)methyl)-5-acetamido-2-(octyloxy)benzamide
(3c). To a solution of 3b (3.52 g, 10 mmol) and triethylamine (1.01 g,
10 mmol) in 60 mL of methylene chloride was added dropwise